Black Hawk Acquisition Corp. Files 8-K

Ticker: BKHAR · Form: 8-K · Filed: Jun 23, 2025 · CIK: 2000775

Black Hawk Acquisition CORP 8-K Filing Summary
FieldDetail
CompanyBlack Hawk Acquisition CORP (BKHAR)
Form Type8-K
Filed DateJun 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, biological-products

TL;DR

BHAC filed an 8-K on 6/23/25, confirming its focus on biological products.

AI Summary

On June 23, 2025, Black Hawk Acquisition Corp. filed an 8-K report. The filing indicates that the company is involved in the biological products sector, specifically excluding diagnostic substances. The report details the company's principal executive office address in Danville, California.

Why It Matters

This filing provides an update on Black Hawk Acquisition Corp.'s corporate status and business sector, which is relevant for investors tracking the company's activities.

Risk Assessment

Risk Level: low — This is a routine filing providing basic corporate information and does not indicate significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Black Hawk Acquisition Corp. as indicated in this filing?

The filing indicates that Black Hawk Acquisition Corp. is in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' sector.

When was this 8-K report filed?

The report was filed on June 23, 2025.

What is the principal executive office address for Black Hawk Acquisition Corp.?

The principal executive office is located at 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.

What is the SEC file number for Black Hawk Acquisition Corp.?

The SEC file number is 001-41984.

What is the fiscal year end for Black Hawk Acquisition Corp.?

The fiscal year end is November 30 (1130).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Black Hawk Acquisition Corp (BKHAR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing